MedTrace Logo

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

NCT02062073 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2020-04-29

No results posted yet for this study

Summary

Purpose of this study will be to determine the potential of abametapir lotion to induce sensitization by repeated topical application to the healthy skin of humans under controlled conditions.

Conditions

  • Head Lice

Interventions

DRUG

Abametapir Lotion 0.74% w/w

OTHER

0.1% sodium lauryl sulfate

OTHER

saline 0.9%

OTHER

Vehicle Lotion

Sponsors & Collaborators

  • TKL Research, Inc.

    collaborator INDUSTRY

  • Accelovance

    collaborator INDUSTRY

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Jonathan Dosik · TKL Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-03-31
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062073 on ClinicalTrials.gov